Skip to main content

Human papillomavirus (HPV) and Meningococcal group B (MenB) Vaccines

The HPV Vaccine is Cancer Prevention

Human papillomavirus (HPV) is the most common sexually transmitted infection within the United States impacting approximately 79 million Americans. Some health effects caused by HPV can be prevented by the HPV vaccine. Below are educational resources to raise awareness about the benefits of the vaccine.

Find the HPV or MenB vaccines near you.

Provider Resources

Additional guidance for providers regarding 9-valent HPV vaccine used among persons who previously received 2-valent HPV or 4-valent HPV vaccine is available.

Meningococcal group B (MenB) Vaccine

Meningococcal group B (MenB) vaccine are now available through the Vaccines For Children (VFC) Program for ages 16-18 years. This includes adolescents and young adults who do not have a condition or are not in a situation which increases their risk for Serogroup B meningococcal disease.

Meningococcal B Recommendations for persons age ≥10 years at increased risk for Serogroup B Meningcoccal Disease


Contact Information

Mailing Address
Oklahoma State Department of Health
Immunization Service
123 Robert S. Kerr Ave., Suite 1702
Oklahoma City, OK 73102-6406

Physical Location
Oklahoma State Department of Health
123 Robert S. Kerr Ave.
Oklahoma City, OK

Phone: (405) 426-8580
Fax: (405) 900-7612